Testing effectiveness (Phase 2)Looking for participantsNCT06154291What this trial is testingFIH XON7 in Advanced/Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Cancer Xenothera SAS 255
Testing effectiveness (Phase 2)Study completedNCT03370718What this trial is testingCabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical CarcinomaWho this might be right forMetastatic Carcinoma in the Adrenal CortexStage III Adrenal Cortex Carcinoma AJCC v8Stage IV Adrenal Cortex Carcinoma AJCC v8+1 more M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT05892926What this trial is testingHER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in RussiaWho this might be right forAdenocarcinoma AstraZeneca 204
Testing effectiveness (Phase 2)Study completedNCT00471276What this trial is testingEfficacy And Safety Of Sunitinib In Women With Advanced Breast CancerWho this might be right forBreast Neoplasms Pfizer 83
Early research (Phase 1)Active Not RecruitingNCT04696731What this trial is testingSafety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced/Metastatic Clear Cell Renal Cell Carcinoma Allogene Therapeutics 120
Testing effectiveness (Phase 2)Study completedNCT00802945What this trial is testingStudy to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast CancerWho this might be right forTumorBreast Cancer Nektar Therapeutics 70
Testing effectiveness (Phase 2)Ended earlyNCT02472977What this trial is testingSafety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid TumorsWho this might be right forSolid Tumor Bristol-Myers Squibb 61
Testing effectiveness (Phase 2)Study completedNCT00118157What this trial is testingLapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TamoxifenWho this might be right forEstrogen Receptor PositiveMale Breast CarcinomaProgesterone Receptor Positive+4 more National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT05989828What this trial is testingA2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast CancerWho this might be right forTriple Negative Breast Cancer University of Southern California 20
Large-scale testing (Phase 3)Study completedNCT00556712What this trial is testingTarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 889
Testing effectiveness (Phase 2)Study completedNCT00744900What this trial is testingPemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer University Hospital, Brest 45
Testing effectiveness (Phase 2)Looking for participantsNCT06769152What this trial is testingA Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant TumorsWho this might be right forCervical CancerOvarian Cancer Shanghai Henlius Biotech 190
Testing effectiveness (Phase 2)Study completedNCT00087958What this trial is testingIntravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine TreatmentWho this might be right forBreast Cancer Sanofi 168
Post-approval studies (Phase 4)Study completedNCT02596035What this trial is testingAn Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 197
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Looking for participantsNCT07025889What this trial is testingIBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerWho this might be right forGastric Cancer Ruijin Hospital 55
Not applicableStudy completedNCT06478368What this trial is testingPrediction of Occult Peritoneal Metastasis of Locally Advanced Gastric Cancer Using Multimodal Data Based on Artificial Intelligence Combined With Intraoperative Dynamic VideoWho this might be right forThis Study Uses AI and Multimodal Data to Noninvasively Detect Occult Peritoneal Metastasis Qun Zhao 1,000
Early research (Phase 1)Active Not RecruitingNCT02817633What this trial is testingTSR-022 in Participants With Advanced Solid Tumors (AMBER)Who this might be right forNeoplasms Tesaro, Inc. 463
Testing effectiveness (Phase 2)Study completedNCT04405349What this trial is testingInvestigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical CancerWho this might be right forCervical CancerCervix Cancer Nykode Therapeutics ASA 52
Not applicableStudy completedNCT01649778What this trial is testingObservational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 662